SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Icebrg3/27/2007 6:21:06 AM
   of 10280
 
Item 8.01 Other Events

On March 23, 2007, Sepracor Inc. (the "Company") received notice that Dey, L.P. and Dey, Inc. ("Dey") had filed a patent infringement complaint against the Company in the United States District Court for the Southern District of New York. The complaint alleges that BROVANATM (arformoterol tartrate) Inhalation Solution 15 mcg, which the Company is on track to commercially introduce during April of 2007 for the maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease, infringes or will induce infringement of a single U.S. patent for which Dey owns all rights, title and interest. The complaint seeks monetary damages in an unspecified amount, injunctive relief, and other relief as determined by the Court. The complaint has not been served on the Company. The Company believes it has strong defenses to the allegations made in the complaint and intends to vigorously defend against this action; however, it is too early to make a reasonable assessment as to the likely outcome or impact of this litigation.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News